A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Clinical trial NCT03942042 · COMPLETED
Trial details
- NCT number
- NCT03942042
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-05
- Primary completion
- 2020-07-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.